IM Cannabis (IMCC) Liabilities and Shareholders Equity (2019 - 2026)

IM Cannabis' Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $17.3 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 44.81% year-over-year to $17.3 million in Q1 2026; TTM through Mar 2026 was $101.9 million, a 16.13% decrease from a year earlier, with the FY2025 full-year figure at $22.8 million, down 20.49% from the prior year.
• Liabilities and Shareholders Equity slipped to $17.3 million in Q1 2026 per IMCC's latest filing, from $22.8 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $221.9 million in Q1 2022 and bottomed at $17.3 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $32.7 million (2024), against an average of $57.5 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 68.93% in 2022 and slumped 81.07% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $44.7 million in 2022, then fell by 19.79% to $35.9 million in 2023, then fell by 21.76% to $28.1 million in 2024, then fell by 18.88% to $22.8 million in 2025, then decreased by 24.06% to $17.3 million in 2026.
• Per Business Quant, the three latest IMCC Liabilities and Shareholders Equity figures stand at $17.3 million (Q1 2026), $22.8 million (Q4 2025), and $32.2 million (Q3 2025).